Cell Collection and Research Center, National Institutes for Food and Drug Control (NIFDC), and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, China.
Adv Exp Med Biol. 2023;1407:85-103. doi: 10.1007/978-981-99-0113-5_5.
Papillomavirus is difficult to culture in vitro, which limits its related research. The development of pseudotyped virus technology provides a valuable research tool for virus infectivity research, vaccine evaluation, infection inhibitor evaluation, and so on. Depending on the application fields, different measures have been developed to generate various kinds of pseudotyped papillomavirus. L1-based and L2-based HPV vaccines should be evaluated using different pseudotyped virus system. Pseudotyped papillomavirus animal models need high-titer pseudotyped virus and unique handling procedure to generate robust results. This paper reviewed the development, optimization, standardization, and application of various pseudotyped papillomavirus methods.
乳头瘤病毒难以在体外培养,这限制了其相关研究。假型病毒技术的发展为病毒感染性研究、疫苗评估、感染抑制剂评估等提供了有价值的研究工具。根据应用领域的不同,已经开发出不同的措施来产生各种假型乳头瘤病毒。基于 L1 和 L2 的 HPV 疫苗应该使用不同的假型病毒系统进行评估。假型乳头瘤病毒动物模型需要高滴度的假型病毒和独特的处理程序来产生可靠的结果。本文综述了各种假型乳头瘤病毒方法的开发、优化、标准化和应用。